Immunodominant protein MIP_05962 from Mycobacterium indicus pranii displays chaperone activity

Ashish Sharma1, Md Javed Equbal1, Saurabh Pandey2

  • 1Kusuma School of Biological Sciences, Indian Institute of Technology Delhi, Hauz Khas, New Delhi, India.

The FEBS Journal
|March 16, 2017
PubMed

Insights

Mycobacterium indicus pranii (MIP) protein MIP_05962, a heat shock protein, functions as a molecular chaperone. It prevents protein aggregation and aids in refolding, offering potential therapeutic applications against diseases like tuberculosis.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Background:

  • Tuberculosis remains a leading cause of global mortality.
  • Mycobacterium indicus pranii (MIP) shows promise as an immunomodulator for tuberculosis treatment.
  • The roles of mycobacterial chaperones and their client proteins require further investigation.

Purpose of the Study:

  • To identify and characterize potential chaperones within the MIP proteome.
  • To investigate the function of MIP_05962, an immunogenic heat shock protein 20 family member.
  • To explore the molecular chaperone activity of MIP_05962.

Main Methods:

  • Biophysical and biochemical characterization of MIP_05962.
  • Assays for protein aggregation prevention and substrate protein refolding.
  • Analysis of protein interactions, surface hydrophobicity, and oligomer formation.
  • In vivo studies including thermal rescue of E. coli and solubility enhancement of MalZ.

Main Results:

  • MIP_05962 demonstrated molecular chaperone activity.
  • The protein prevented aggregation and facilitated refolding of substrate proteins.
  • MIP_05962 interacted with non-native proteins, exhibited surface hydrophobicity, and formed large oligomers.
  • In vivo experiments confirmed its ability to provide thermal protection and enhance protein solubility.

Conclusions:

  • MIP_05962 is confirmed as a functional molecular chaperone.
  • Its properties suggest potential as a therapeutic agent, particularly in combating protein misfolding-related diseases.
  • Further research into MIP_05962 could elucidate novel intervention strategies for tuberculosis and other conditions.